Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsBlood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsBone Marrow TransplantationMyeloablative AgonistsGraft vs Host DiseaseBusulfanTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionBone MarrowRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisHematopoiesisStem CellsCytarabineHodgkin DiseaseDisease-Free SurvivalCord Blood Stem Cell TransplantationTransplantation ChimeraRetrospective StudiesTissue DonorsNeoplasmsSurvival RateRadioimmunotherapyRheniumWhole-Body IrradiationTime FactorsInfectionSurvival AnalysisLymphoma, T-CellDoxorubicinHistocompatibilityPlatelet CountPOEMS SyndromeHistocompatibility TestingPrednisoneCarboplatinImmunosuppressive AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicDexamethasoneSolar ActivityBone Marrow PurgingVidarabineRadiometryBone Marrow CellsBlood Cell CountLeukemiaRecombinant ProteinsFollow-Up StudiesRadioisotopesAntineoplastic AgentsBlood CellsLymphomaCytomegalovirus InfectionsProspective StudiesGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesAnemia, AplasticMyelodysplastic SyndromesImmunophenotypingLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBlood Transfusion, AutologousLymphocyte DepletionLiver TransplantationT-LymphocytesBone Marrow DiseasesRadiotherapy DosageLeukocytes, MononuclearHematologic DiseasesPrecursor Cell Lymphoblastic Leukemia-LymphomaHistiocytosis, Non-Langerhans-CellOpportunistic InfectionsLivedo Reticularis